atezolizumab,vinorelbine
roche
['agent']
innovative study to address 1st line therapy in platinum ineligible patients including ps2 showing improved os with single agent io. addressing a common unmet need. | medpage today 
Medical Oncologist & clinical-translational researcher in lung cancer. Co-Director-Center for Experimental Therapeutics, UC Davis Comprehensive Cancer Center